Last update 06 Dec 2025

CT-0594

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
BCMA-UCAR-T, CT 0594, CT 0594CP
+ [4]
Target
BCMA
Action
inhibitors
Mechanism
BCMA inhibitors(B-cell maturation protein inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Plasma Cell LeukemiaRecurrent Multiple MyelomaRefractory Multiple Myeloma+ [1]
Inactive Indication-
Originator Organization
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
Active Organization
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
Inactive Organization-
License Organization
Ukaize Biopharmaceuticals Shanghai Co. Ltd.CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

2
Clinical Trials associated with CT-0594
NCT05822037
/ RecruitingNot ApplicableIIT
Exploratory Study to Assess the Safety and Efficacy of CT0594CP CAR-T Cells in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT05893693
/ RecruitingNot ApplicableIIT
Open Label, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of CT0594CP in Patients With Relapsed and/or Refractory Multiple Myeloma or Plasma Cell Leukemia
100 Clinical Results associated with CT-0594
Login to view more data
100 Translational Medicine associated with CT-0594
Login to view more data
100 Patents (Medical) associated with CT-0594
Login to view more data
100 Deals associated with CT-0594
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plasma Cell LeukemiaClinical
China
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
12 Apr 2023
Recurrent Multiple MyelomaClinical
China
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
12 Apr 2023
Refractory Multiple MyelomaClinical
China
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
12 Apr 2023
Relapse multiple myelomaClinical
China
CARsgen Therapeutics Co. Ltd.CARsgen Therapeutics Co. Ltd.
12 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free